EOM 1352: Fri 7 June 2024, 11:36
Peli bio 14 April 2021, 14:42
PCI 7 November 2023, 15:57
Catalyst 7 July 2023, 14:52
PCI 16 February 2023, 11:57
Temperature Controlled Logistics 23 September 2022, 13:48
Clinical Trial Supply Europe 2023 23 September 2022, 13:52
Tower Fri 5 August 2022, 09:22
DWL 10 June 2022, 15:36
Aptus 17 March 2022, 15:02
Topra 30 April 2021, 11:02
ICON 1 March 2021, 14:50
Illingworth 8 February 2021, 10:48
Signant Health
Europital 23/04/2019
RWS+Banner
Synlab+Banner
Media Pack
News

Current Edition

Volume 16 Issue 3

Current Features

Current features

Site Selection in Clinical Trials: Current Challenges and Future Opportunities

Site selection is a crucial step in clinical research as it affects the quality, efficiency, and cost of the clinical trial. However, many challenges exist in the cu...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Settling the Score with Scleroderma While Waiting for a Cure:

Scleroderma, also called systemic sclerosis (SSc), is a rare, progressive autoimmune connective tissue disorder with no cure. It causes inflammation in the skin and ...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

The Expanding Role of Functional Service Providers in Clinical Research

Functional service providers (FSPs) are reshaping clinical research by offering specialised skills and adaptable resources. As trials become more complex, many biote...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Striking the Right Balance Between Transparency and Privacy in Clinical Trial Data Sharing

Clinical trial researchers must balance the at times contradictory needs for transparency, with protecting participants’ privacy and looking after companies' intelle...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Generating Entire Regulatory Dossiers – The Logical Next Step for GenAI in Life Sciences?

Generating Entire Regulatory Dossiers – The Logical Next Step for GenAI in Life Sciences? Generative AI (GenAI)’s ability to digest, assess and summarise key insi...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Making AI Work for Drug Discovery: A Joined-up Approach

AI/data-driven drug discovery is starting to evolve at an encouraging rate now. But the technology’s positive impact will depend on how well the technology, and the ...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →

Advertisement

Current Edition

Volume 16 Issue 3
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Current features

Site Selection in Clinical Trials: Current Challenges and Future Opportunities

Site selection is a crucial step in clinical research as it affects the quality, efficiency, and cost of the clinical trial. However, many challenges exist in the cu...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Settling the Score with Scleroderma While Waiting for a Cure:

Scleroderma, also called systemic sclerosis (SSc), is a rare, progressive autoimmune connective tissue disorder with no cure. It causes inflammation in the skin and ...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

The Expanding Role of Functional Service Providers in Clinical Research

Functional service providers (FSPs) are reshaping clinical research by offering specialised skills and adaptable resources. As trials become more complex, many biote...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Striking the Right Balance Between Transparency and Privacy in Clinical Trial Data Sharing

Clinical trial researchers must balance the at times contradictory needs for transparency, with protecting participants’ privacy and looking after companies' intelle...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Generating Entire Regulatory Dossiers – The Logical Next Step for GenAI in Life Sciences?

Generating Entire Regulatory Dossiers – The Logical Next Step for GenAI in Life Sciences? Generative AI (GenAI)’s ability to digest, assess and summarise key insi...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Current features

Making AI Work for Drug Discovery: A Joined-up Approach

AI/data-driven drug discovery is starting to evolve at an encouraging rate now. But the technology’s positive impact will depend on how well the technology, and the ...
23 October 2024 Current features | Volume 16 Issue 3
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Pharmap: Wed 13 November 2024, 10:36
Biosynth: Wed 13 November 2024, 10:18

Company Profiles

Emmes
Company Profile

Emmes

The Industry’s First Native Digital and AI Specialty CRO Advancing human health with scientific rigor and integrity Welcome to Emmes, a full-service clinical r...
17 April 2024 Company Profile | E-M
Continue Reading →
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte